Cargando…
Hepatitis C Virus Relapse After Ultrashort Direct-Acting Antiviral Therapy Associates With Expression of Genes Involved With Natural Killer-Cell and CD8(+) T-Cell Function
To identify immunologic correlates of hepatitis C virus (HCV) relapse after direct-acting antiviral (DAA) therapy, we quantified select immune transcripts in whole blood from noncirrhotic HCV subjects treated with 4–6 weeks of DAAs. We identified specific markers of natural killer-cell and CD8(+) T-...
Autores principales: | Orr, Cody, Masur, Henry, Kottilil, Shyam, Meissner, Eric G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082583/ https://www.ncbi.nlm.nih.gov/pubmed/33959672 http://dx.doi.org/10.1093/ofid/ofab118 |
Ejemplares similares
-
Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
por: Orr, Cody, et al.
Publicado: (2020) -
Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection
por: Meissner, Eric G., et al.
Publicado: (2017) -
Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin
por: Meissner, Eric G., et al.
Publicado: (2014) -
Multitarget Direct‐Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus
por: Shrivastava, Shikha, et al.
Publicado: (2018) -
HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis
por: Poonia, Bhawna, et al.
Publicado: (2018)